Abstract
Aldosterone is a potent mineralocorticoid synthesized by the outer zone of the adrenal cortex, the zona glomerulosa. Production of aldosterone is stimulated by angiotensin and potassium, but may also be affected by over 20 other endogenous and exogenous substances. Because of its sensitivity to angiotensin, secretion of aldosterone is altered by diseases that affect the kidneys and perturb their release of renin. Examples include renal artery stenos is, which increase s renin secretion, and diabetes, which reduces it. Other disease s that reduce perfusion of the kidneys also alter aldosterone secretion. Examples include heart failure and cirrhos is of the liver, both of which stimulate renin release and increa se ald ostero ne sec ret io n. Disorders of the adrenal cortex can affect aldosterone secretion. Adenomas of th e zona glomerulosa overproduce aldosterone independent of angiotensin. Hypertrophy of the zona glomerulosa causes overproduction of aldosterone because the cells are hypersensitive to angiotensin. The role of aldosterone in common cardiovascular diseases such as heart failure, low-renin essential hypertension, and the hypertension that accompanies obesity, is uncertain. The growing use of plasma aldosterone and renin measurements and the development of new aldosterone antagonists should clarify the importance of this steroid in a variety of disease states
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bakris GL, Gavras H (1993) Renin in acute and chronic renal failure: implications for treatment. In: Robertson JIS, Nicholls MG(eds) The renin -angiotensin system, vol 2. Gower, London, pp 56.1–56.14
Biglieri EG, Herron MA, Brust N (1966) 17-Hydroxylation deficiency in man. J Clin Invest 45:1946–1954
Brown JJ, Lever AF, Robertson JI, et al (1979) Are idiopathic hyperaldo steronism and low-renin hypertension variants of essential hypertension? Ann Clin Biochem 16:380–388
Brown NJ, Kim K-S, Chen Y-Q, Blevins LS, Nadeau JH, Meranze SG, Vaughan DE (2000) Synergistic effect of adrenal steroid s and angiotensin 11 on plasminogen activator inhibitor-I production. J Clin Endocrinol Metab 85:336–344
Brown RD, Wisgerhof M, Carpenter PC, Brown G, Jiang N-S, Kao P, Hegstad R (1979) Adrenal sensitivity to angiotensin 11 and undiscovered aldosterone stimulating factors in hypertension. J Steroid Biochem 11:1043–1050
Burmeister P, Scholmerich J, Diener W, Gerok W (1986) Renin, aldosterone and arginine vasopressin in patients with liver cirrhosis: The influence of ascites retransfusion. Eur J Clin Invest 16:117–123
Cain JP, Tuck ML, Williams GH et al (1972) The regulation of aldosterone secretion in primary aldosteronism. Am J Med 53:627–637
Carey RM (1982) Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin 11 and adrenocorticotropin. J Clin Endocrinol Metab 54:463–469
Cody RJ, Covit AB, Schaer GL, Laragh JH, Sealey JE, Feldschuh J (1986) Sodium and water balance in chronic congestive heart failure. J Clin Invest 77:1441–1452
Conlin PR, Moore TJ, Williams GH, Hollenberg NK (1993) Rapid modulation of renal and adrenal respon siveness to angiotensin 11. Hyperten sion 22:832–838
Conn JW, Knopf RF, Nesbit RM (1964) Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg 107:159–172
De Chatel R, Weidmann P, Flammer J, Ziegler WH, Beretta-Piccoli C, Vetter W, Reubi FC (1977) Sodium, renin, aldosterone, catecholamin es and blood pressure in diabetes mellitus. Kidney Int 12:412–421
Edwards CRW, Hayman A (1991) Enzyme protection of the mineralocorticoid receptor: evidence in favour of the hemi-acetal structure of aldosterone. In: Bonvalet JP et al. (eds) Aldosterone: fundamental aspects. John Libbey Eurotext, London, pp 67–76
Ehrhart-Bornstein M, Hinson J, Bornstein S, Scherbaum W, Vinson G (1998) Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 19:101–143
Findling JW, Waters VD, Raff H (1987) The dissociation of renin and aldosterone during critical illness. J Clin Endocrinol Metab 64:592–595
Goodfriend TL, Ball DL, Elliott ME, Chabhi A, Duong T, Raff H, Schneider EG, Brown RD, Weinberger MH (1993) Fatty acids may regulate aldosterone secretion and mediate some of insulin’s effects on blood pressure. Prostaglandins Leukot Essent Fatty Acids 48:43–50
Goodfriend TL, Elliott ME, Atlas SA (1984) Actions of synthetic atrial natriuretic factor on bovine adrenal glomerulosa. Life Sci 35:1675–1682
Goodfriend TL, Egan BM, Kelley DE (1998) Aldosterone in obesity. Endocr Res 24:789–796
Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ (1999) Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res 7:355362
Goodfriend TL, Ball DL, Gardner HW (2002) An oxidized derivative of linoleic acid affects aldosterone secretion by adrenal cells in vitro. Prostaglandins Leukot Essent Fatty Acids 67:163–167
Gordon RD, Klemm SA, Tunny TJ (1993) Renin in Bartter’s syndrome. In: Robertson IS, Nicholls MG (eds) The renin-angiotensin system, vol 2. Gower, London, pp 64.1–64.15
Greene EL, Kren S, Hostetter TH (1996) Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 98:1063–1068
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Goodfriend, T. (2004). Aldosterone: Clinical Aspects. In: Angiotensin Vol. II. Handbook of Experimental Pharmacology, vol 163 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18497-0_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-18497-0_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-40641-9
Online ISBN: 978-3-642-18497-0
eBook Packages: Springer Book Archive